Drug Shortage Report for TEVA-SOLIFENACIN
| Report ID | 151465 |
| Drug Identification Number | 02397900 |
| Brand name | TEVA-SOLIFENACIN |
| Common or Proper name | SOLIFENACIN 5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SOLIFENACIN SUCCINATE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-12-14 |
| Estimated end date | 2024-06-10 |
| Actual end date | 2024-05-29 |
| Shortage status | Resolved |
| Updated date | 2024-05-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v44 | 2024-05-30 | French | Compare |
| v43 | 2024-05-30 | English | Compare |
| v42 | 2024-05-23 | French | Compare |
| v41 | 2024-05-23 | English | Compare |
| v40 | 2023-11-03 | French | Compare |
| v39 | 2023-11-03 | English | Compare |
| v38 | 2023-10-04 | French | Compare |
| v37 | 2023-10-04 | English | Compare |
| v36 | 2023-08-08 | French | Compare |
| v35 | 2023-08-08 | English | Compare |
| v34 | 2023-07-27 | French | Compare |
| v33 | 2023-07-27 | English | Compare |
| v32 | 2023-06-08 | French | Compare |
| v31 | 2023-06-08 | English | Compare |
| v30 | 2023-04-27 | French | Compare |
| v29 | 2023-04-27 | English | Compare |
| v28 | 2023-02-16 | French | Compare |
| v27 | 2023-02-16 | English | Compare |
| v26 | 2023-01-19 | French | Compare |
| v25 | 2023-01-19 | English | Compare |